Bridgeway Capital Management, LLC Adicet Bio, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.24 Billion
- Q4 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 1,026,600 shares of ACET stock, worth $995,802. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,026,600
Previous 851,600
20.55%
Holding current value
$995,802
Previous $1.23 Million
19.66%
% of portfolio
0.02%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding ACET
# of Institutions
71Shares Held
59MCall Options Held
7.3KPut Options Held
39.3K-
Orbimed Advisors LLC San Diego, CA11.4MShares$11.1 Million0.3% of portfolio
-
Tang Capital Management LLC San Diego, CA8.15MShares$7.9 Million0.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$7.31 Million0.12% of portfolio
-
Goldman Sachs Group Inc New York, NY3.75MShares$3.64 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$3.11 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $38.8M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...